NASDAQ:AMRS - Nasdaq - US03236M2008 - Common Stock - Currency: USD
Donna Shiroma retires after distinguished service as General Counsel
Mentions: RCEL
Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028.
Gainers PhenomeX Inc. (NASDAQ: CELL) shares surged 138.3% to $0.9532. Bruker Corporation and PhenomeX reported a $108 million definitive agreement for Bruker to acquire PhenomeX in an all-cash transaction for $1 per share.
Investors will want to get ready for another busy day of trading as we cover the biggest pre-market stock movers for Wednesday!
We're starting the week off right with a breakdown of the biggest pre-market stock movers worth knowing about on Monday morning!
/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through...
Amyris (AMRS) stock is rising higher on Friday with heavy trading after the biotechnology company recently filed for bankruptcy.
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday!
Roblox (RBLX) stock is on the rise Thursday as investors in the video game company react to an upgrade from Wedbush analyst Nick McKay.
Applied UV (AUVI) stock is on the move Thursday as investors react to the disinfectant company getting $4 million in orders.
Amyris (AMRS) stock is falling on Thursday after the company filed for Chapter 11 bankruptcy protection to facilitate a restructuring.
We're starting off the day with a breakdown of the biggest pre-market stock movers traders should watch on Thursday morning!
Amyris (AMRS) said it filed Chapter 11 bankruptcy proceedings and is planning to sell its consumer brands to improve the company's liquidity position.
/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris" or the "Company"), a leading synthetic biotechnology company accelerating the world's transition to...
Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July.
Ready to make sense of the market's laggards? The share prices of these high-octane growth stocks are falling in 2023, so it might be time to bet on rebounds -- but only some of them.
Synthetic biotechnology company, Amyris (AMRS) Board of Directors will execute on a transformation program to accelerate improvements to the company's cost and capital structure...
/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through...